133 related articles for article (PubMed ID: 8959052)
1. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
[No Abstract] [Full Text] [Related]
2. Substrate transport and cocaine binding of human dopamine transporter is reduced by substitution of carboxyl tail with that of bovine dopamine transporter.
Lee SH; Cho HK; Son H; Lee YS
Neuroreport; 1997 Jul; 8(11):2591-4. PubMed ID: 9261833
[TBL] [Abstract][Full Text] [Related]
3. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
Lee SH; Rhee J; Koh JK; Lee YS
Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine.
Mitsuhata C; Kitayama S; Morita K; Vandenbergh D; Uhl GR; Dohi T
Brain Res Mol Brain Res; 1998 May; 56(1-2):84-8. PubMed ID: 9602072
[TBL] [Abstract][Full Text] [Related]
5. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
Kitayama S; Morita K; Dohi T
Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
[TBL] [Abstract][Full Text] [Related]
6. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function.
Lee SH; Kang SS; Son H; Lee YS
Biochem Biophys Res Commun; 1998 May; 246(2):347-52. PubMed ID: 9610361
[TBL] [Abstract][Full Text] [Related]
7. MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters.
Kitayama S; Mitsuhata C; Davis S; Wang JB; Sato T; Morita K; Uhl GR; Dohi T
Biochim Biophys Acta; 1998 Sep; 1404(3):305-13. PubMed ID: 9739158
[TBL] [Abstract][Full Text] [Related]
8. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter.
Carroll FI; Lewin AH; Boja JW; Kuhar MJ
J Med Chem; 1992 Mar; 35(6):969-81. PubMed ID: 1552510
[No Abstract] [Full Text] [Related]
9. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Van Kampen JM; McGeer EG; Stoessl AJ
Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
11. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
12. Expression of a single dopamine transporter cDNA can confer two cocaine binding sites.
Boja JW; Markham L; Patel A; Uhl G; Kuhar MJ
Neuroreport; 1992 Mar; 3(3):247-8. PubMed ID: 1515577
[TBL] [Abstract][Full Text] [Related]
13. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
Uhl G; Lin Z; Metzger T; Dar DE
Methods Enzymol; 1998; 296():456-65. PubMed ID: 9779467
[No Abstract] [Full Text] [Related]
15. The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter.
Vrindavanam NS; Arnaud P; Ma JX; Altman-Hamamdzic S; Parratto NP; Sallee FR
Neurosci Lett; 1996 Sep; 216(2):133-6. PubMed ID: 8904801
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.
Shimada S; Kitayama S; Lin CL; Patel A; Nanthakumar E; Gregor P; Kuhar M; Uhl G
Science; 1991 Oct; 254(5031):576-8. PubMed ID: 1948034
[TBL] [Abstract][Full Text] [Related]
17. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
Xu C; Reith ME
J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
20. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
